OCUL
Ocular Therapeutix Inc
9.80$
-1.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.9% | -0.2% | +11.3% | -6.2% | +10.7% | -37.4% | +25.8% | +8.1% | -8.9% | -18.6% | +24.9% | – | |
| – | +0.7% | -4.3% | +13.8% | +3.4% | -21.2% | +2.6% | +54.0% | -8.7% | -10.1% | -16.6% | +51.3% | – | |
| – | -2.1% | +0.2% | +11.0% | -7.2% | +14.3% | -40.5% | +22.0% | +10.9% | -8.7% | -18.9% | +21.2% | – | |
| – | +7.8% | +28.0% | +39.2% | +28.4% | +10.6% | +4.6% | +19.2% | +2.5% | -3.0% | +30.3% | -18.2% | – | |
| – | +159.0% | -47.3% | -14.7% | -37.8% | +97.1% | +20.0% | -8.2% | -39.7% | +10.2% | +13.3% | +10.8% | – | |
| – | +1.7% | +34.7% | +29.9% | +2.3% | +11.0% | +10.4% | +7.9% | +2.9% | -0.1% | +26.3% | -9.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +21.2% | -2.4% | -21.1% | +0.9% | -3.7% | -3.9% | +1.1% | -0.5% | -5.7% | -1.9% | +0.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -734.5% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.